Morbidity and medicine prescriptions in a nationwide Danish population of patients diagnosed with polycystic ovary syndrome
The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.
Abstract
Objective: The prevalence of type 2 diabetes is increased in polycystic ovary syndrome (PCOS), but the prevalence of other diseases is not clarified. We aimed to investigate morbidity and medicine prescriptions in PCOS. Design: A National Register-based study. Methods: Patients with PCOS (PCOS Denmark and an embedded cohort; PCOS Odense University Hospital (OUH)) and one control population. Premenopausal women with PCOS underwent clinical and biochemical examination (PCOS OUH,n=1217). PCOS Denmark (n=19 199) included women with PCOS in the Danish National Patient Register. Three age-matched controls were included per patient (n=57 483). Main outcome measures: Diagnosis codes and filled prescriptions. Results: The mean (range) age of the PCOS Denmark group and controls was 30.6 (12–60) years. Patients in PCOS Denmark had higher Charlson index, higher prevalence of diabetes, dyslipidemia, and hypertension than controls. PCOS was associated with a two times increased risk of stroke and thrombosis, whereas the risk of other cardiovascular diseases was not increased. Thyroid disease, asthma, migraine, and depression were more prevalent in PCOS Denmark vs controls, whereas fractures were rarer. Infertility was increased in patients compared with controls, but the mean number of births was higher in PCOS. Medicine prescriptions within all diagnosis areas were significantly higher in PCOS patients than in controls. In PCOS OUH, polycystic ovaries (PCO) and irregular menses were associated with a more adverse metabolic risk profile, but individual Rotterdam criteria were not associated with cardiometabolic diagnoses. Conclusion: Cardiometabolic and psychiatric morbidity were significantly increased in a Danish population with PCOS. Medical diseases are frequent also in young patients with PCOS.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Few population studies have been conducted on the range of morbidities that are experienced in women with PCOS, as compared to age-matched controls across the lifespan—adolescence, reproductive age, the menopausal period, and the elderly years.2,31, 32, 33”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [32]
In the citing paper
“The prevalence of malignant cancer has been reported to be 2-fold greater or not different in those with PCOS.6,32”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [32]
In the citing paper
“Those with PCOS appear to have a higher risk of developing asthma, and the level of use of asthma medication prescriptions is reported to be higher in those with PCOS.32,122”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [32]
In the citing paper
“Our data showed that mental health and psychiatric disorders had a 30% higher prevalence in those with PCOS, consistent with findings of previous population cohort studies.6,29,31,32,126,127”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [32]
In the citing paper
“In particular, the prevalence of depression and anxiety in those with PCOS has been reported to be markedly elevated, with a 30%-50% prevalence and an odds ratio of 1.4 to > 2.5 in those with PCOS.7,29,32,127,128”
From Increased Prevalence of Adverse Health Outcomes Across the Lifespan in Those Affected by Polycystic Ovary Syndrome: A Canadian Population Cohort (2024) · cites this paper as [32]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Charlson, M. E., Pompei, P., Ales, K. L., & MacKenzie, C. R. (1987) · Journal of Chronic Diseases · doi:10.1016/0021-9681(87)90171-8 · Cited by 49,742
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Danish National Patient Register
Lynge, E., Sandegaard, J. L., & Rebolj, M. (2011) · Scandinavian Journal of Public Health · doi:10.1177/1403494811401482 · Cited by 3,968
CLINICAL ASSESSMENT OF BODY HAIR GROWTH IN WOMEN
FERRIMAN, D., & GALLWEY, J. D. (1961) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-21-11-1440 · Cited by 2,506
Men at risk: occupation and male infertility
Claman, P. (2004) · Fertility and Sterility · doi:10.1016/s0015-0282(03)01188-9 · Cited by 2,387
Azziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0178 · Cited by 2,143
Legro, R. S., Arslanian, S. A., Ehrmann, D. A., Hoeger, K. M., Murad, M. H., Pasquali, R., & Welt, C. K. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-2350 · Cited by 1,919
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Sirmans, S., & Pate, K. (2013) · Clinical Epidemiology · doi:10.2147/clep.s37559 · Cited by 1,302
Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.
Ehrmann, D. A., Barnes, R. B., Rosenfield, R. L., Cavaghan, M. K., & Imperial, J. (1999) · Diabetes Care · doi:10.2337/diacare.22.1.141 · Cited by 1,257
Androgen Excess in Women: Experience with Over 1000 Consecutive Patients
Azziz, R., Sanchez, L. A., Knochenhauer, E. S., Moran, C., Lazenby, J., Stephens, K. C., Taylor, K., & Boots, L. R. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031122 · Cited by 1,132
Wild, S., Pierpoint, T., McKeigue, P., & Jacobs, H. (2000) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2000.01000.x · Cited by 970
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Dahlgren, E., Janson, P. O., Johansson, S., Lapidus, L., & Odén, A. (1992) · Acta Obstetricia et Gynecologica Scandinavica · doi:10.3109/00016349209006227 · Cited by 548
Mortality of Women with Polycystic Ovary Syndrome at Long-term Follow-up
Pierpoint, T., McKeigue, P. M., Isaacs, A. J., Wild, S. H., & Jacobs, H. S. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00035-3 · Cited by 504
Escobar-Morreale, H. F., Carmina, E., Dewailly, D., Gambineri, A., Kelestimur, F., Moghetti, P., Pugeat, M., Qiao, J., Wijeyaratne, C. N., Witchel, S. F., et al. (2012) · Human Reproduction Update · doi:10.1093/humupd/dmr042 · Cited by 494
Reid, I. R. (1992) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.75.3.779 · Cited by 421
Insulin Sensitivity and Its Measurement: Structural Commonalities among the Methods1
Radziuk, J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.12.7025 · Cited by 284
O'Reilly, M. W., Taylor, A. E., Crabtree, N. J., Hughes, B. A., Capper, F., Crowley, R. K., Stewart, P. M., Tomlinson, J. W., & Arlt, W. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-3399 · Cited by 283
Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome
Moghetti, P., Tosi, F., Bonin, C., Di Sarra, D., Fiers, T., Kaufman, J.-M., Giagulli, V. A., Signori, C., Zambotti, F., Dall'Alda, M., et al. (2013) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-3908 · Cited by 262
Jones, G. L., Hall, J. M., Balen, A. H., & Ledger, W. L. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm030 · Cited by 243
The evaluation and management of hirsutism*1
AZZIZ, R. (2003) · Obstetrics & Gynecology · doi:10.1016/s0029-7844(02)02725-4 · Cited by 236
Polycystic Ovary Syndrome Is a Risk Factor for Type 2 Diabetes
Gambineri, A., Patton, L., Altieri, P., Pagotto, U., Pizzi, C., Manzoli, L., & Pasquali, R. (2012) · Diabetes · doi:10.2337/db11-1360 · Cited by 225
Mani, H., Levy, M. J., Davies, M. J., Morris, D. H., Gray, L. J., Bankart, J., Blackledge, H., Khunti, K., & Howlett, T. A. (2013) · Clinical Endocrinology · doi:10.1111/cen.12068 · Cited by 194
Depression, anxiety and cardiometabolic risk in polycystic ovary syndrome
Cinar, N., Kizilarslanoglu, M. C., Harmanci, A., Aksoy, D. Y., Bozdag, G., Demir, B., & Yildiz, B. O. (2011) · Human Reproduction · doi:10.1093/humrep/der338 · Cited by 168
Glintborg, D., & Andersen, M. (2010) · Gynecological Endocrinology · doi:10.3109/09513590903247873 · Cited by 159
Self-citationLife-course origins of the ages at menarche and menopause
Forman, M. R., Mangini, L. D., Jean, R. T., & Hayward (2013) · Adolescent Health Medicine and Therapeutics · doi:10.2147/ahmt.s15946 · Cited by 154
Hung, J.-H., Hu, L.-Y., Tsai, S.-J., Yang, A. C., Huang, M.-W., Chen, P.-M., Wang, S.-L., Lu, T., & Shen, C.-C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0097041 · Cited by 152
Morgan, C. L., Jenkins-Jones, S., Currie, C. J., & Rees, D. A. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-1690 · Cited by 136
Gronich, N., Lavi, I., & Rennert, G. (2011) · Canadian Medical Association Journal · doi:10.1503/cmaj.110463 · Cited by 135
Glintborg, D., Henriksen, J. E., Andersen, M., Hagen, C., Hangaard, J., Rasmussen, P. E., Schousboe, K., & Hermann, A. P. (2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2004.06.040 · Cited by 134
Self-citationBird, S. T., Hartzema, A. G., Brophy, J. M., Etminan, M., & Delaney, J. A. C. (2013) · Canadian Medical Association Journal · doi:10.1503/cmaj.120677 · Cited by 126
Cussons, A. J., Stuckey, B. G. A., Walsh, J. P., Burke, V., & Norman, R. J. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2004.02208.x · Cited by 119
LYKKESFELDT, G., BENNETT, P., LYKKESFELDT, A. E., MICIC, S., MØLLER, S., & SVENSTRUP, B. (1985) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1985.tb01096.x · Cited by 105
Correlations between insulin sensitivity and bone mineral density in non‐diabetic men
Abrahamsen, B., Rohold, A., Henriksen, J. E., & Beck‐Nielsen, H. (2000) · Diabetic Medicine · doi:10.1046/j.1464-5491.2000.00234.x · Cited by 102
Self-citationSerologic markers of autoimmunity in women with polycystic ovary syndrome
Hefler‐Frischmuth, K., Walch, K., Huebl, W., Baumühlner, K., Tempfer, C., & Hefler, L. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2009.01.056 · Cited by 94
Glintborg, D., Mumm, H., Hougaard, D., Ravn, P., & Andersen, M. (2010) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03873.x · Cited by 75
Self-citationRespiratory health in women: from menarche to menopause
Macsali, F., Svanes, C., Bjørge, L., Omenaas, E. R., & Real, F. G. (2012) · Expert Review of Respiratory Medicine · doi:10.1586/ers.12.15 · Cited by 69
Tomlinson, J., Millward, A., Stenhouse, E., & Pinkney, J. (2010) · Diabetic Medicine · doi:10.1111/j.1464-5491.2010.02994.x · Cited by 66
Testosterone pellet implants and migraine headaches: A pilot study
Glaser, R. L., Dimitrakakis, C., Trimble, N. J., & Martin, V. T. (2012) · Maturitas · doi:10.1016/j.maturitas.2012.01.006 · Cited by 66
FAGLIA, G., BECK‐PECCOZ, P., FERRARI, C., AMBROSI, B., SPADA, A., & TRAVAGLINI, P. (1973) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1973.tb00421.x · Cited by 64
Cardiovascular Risk and Subclinical Cardiovascular Disease in Polycystic Ovary Syndrome
Bajuk Studen, K., Jensterle Sever, M., & Pfeifer, M. (2013) · Frontiers of Hormone Research · doi:10.1159/000341838 · Cited by 51
Schmidt, J., Dahlgren, E., Brännström, M., & Landin‐Wilhelmsen, K. (2012) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2012.04378.x · Cited by 48
De Frene, V., Vansteelandt, S., T'Sjoen, G., Gerris, J., Somers, S., Vercruysse, L., & De Sutter, P. (2014) · Human Reproduction · doi:10.1093/humrep/deu154 · Cited by 47
Al-Saab, R., & Haddad, S. (2014) · Intern J Endocrinol Metab · doi:10.5812/ijem.17954 · Cited by 43
Glintborg, D., Andersen, M., Hagen, C., & Hermann, A. P. (2005) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2005.02280.x · Cited by 40
Self-citationPolycystic ovary syndrome and chronic autoimmune thyroiditis
Mayrink, J., Benetti‐Pinto, C. L., Garmes, H. M., Jales, R. M., & Juliato, C. R. T. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.958990 · Cited by 38
Thomson, R. L., Spedding, S. J., Brinkworth, G. D., Noakes, M., & Buckley, J. D. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.12.042 · Cited by 38
MATYSIAK-BURZYŃSKA, Z. E., Ochędalski, T., & Piastowska‐Ciesielska, A. W. (2014) · Gynecological Endocrinology · doi:10.3109/09513590.2014.958991 · Cited by 30
Bone mineral density in women with idiopathic hirsutism
Gregoriou, O., Kouskouni, E., Bakas, P., Konidaris, S., Papadias, K., Kalovidouris, A. A., & Creatsas, G. C. (2000) · Gynecological Endocrinology · doi:10.3109/09513590009167704 · Cited by 22
Bone mineral density and vitamin D in PCOS and hirsutism
Glintborg, D., Hermann, A. P., & Andersen, M. (2013) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.2013.827384 · Cited by 20
Self-citationAltinok, M. L., Glintborg, D., dePont Christensen, R., Hallas, J., & Andersen, M. (2014) · Clinical Endocrinology · doi:10.1111/cen.12365 · Cited by 20
Self-citationHyperandrogenism during puberty in the development of polycystic ovary syndrome
Nader, S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.03.013 · Cited by 17
Dihydrotestosterone may contribute to the development of migraine headaches.
Check, J. H., & Cohen, R. E. (2013) · PubMed · Cited by 9
A SYSTEM FOR THE MEASUREMENT OF INTEGRATED CONCENTRATIONS OF HORMONES IN THE BLOOD
Daggett, P. (1976) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1976.tb03862.x · Cited by 7
Computerized Surveillance of Diabetic Patient/Health Care Delivery System Interfaces
Bryant, D., Son, A. V., Davis, P. J., & Segal, C. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.141 · Cited by 5
Research works printed but not linked: 47
- 2014, EUROPEAN JOURNAL ENDOCRINOLOGY, 4, 1
- 2010, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 4, 281
- 2003, Obstetrics & Gynecology, 5, 995
- 2013, Journal of Clinical Endocrinology & Metabolism, 4, E628
- 1999, Diabetes Care, 1, 141
- 2004, Fertility and sterility, 6, 1570
- 2010, Diabetic medicine : a journal of the British Diabetic Association, 5, 498
- 1998, Journal of clinical epidemiology, 7, 581
- 2000, Clinical endocrinology, 5, 595
- 1992, Acta obstetricia et gynecologica Scandinavica, 8, 599
- 2013, Clinical endocrinology, 6, 926
- 2010, Journal of Clinical Endocrinology & Metabolism, 5, 2038
- 2010, Fertility and sterility, 7, 2291
- 2014, INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 3, 17954e
- 2012, EXPERT REVIEW OF RESPIRATORY MEDICINE, 2, 187
- 2011, Human Reproduction, 12, 3339
- 2008, Human Reproduction Update, 1, 15
- 2013, Clinical endocrinology, 80, 884
- 2004, Journal of Clinical Endocrinology & Metabolism, 2, 453
- 2012, Human Reproduction Update, 2, 146
- 2006, Journal of Clinical Endocrinology & Metabolism, 11, 4237
- 1985, Clinical endocrinology, 4, 385
- 2000, Journal of Clinical Endocrinology & Metabolism, 12, 4426
- 2013, Fertility and sterility, 1, 39
- 2013, ADOLESCENT HEALTH MEDICINE AND THERAPEUTICS, 4, 1
- 1987, Journal of chronic diseases, 5, 373
- 2005, Medical care, 11, 1130
- 2012, Journal of Clinical Endocrinology & Metabolism, 9, 3251
- 2012, Diabetes, 9, 2369
- 2010, Clinical endocrinology, 6, 732
- 2013, CMAJ CANADIAN MEDICAL ASSOCIATION JOURNAL, 2, 115E
- 2011, CMAJ CANADIAN MEDICAL ASSOCIATION JOURNAL, 18, E1319
- 2014, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 31, 1
- 2014, 5, e97041
- 2012, Maturitas, 4, 385
- 2013, CLINICAL AND EXPERIMENTAL OBSTETRICS GYNECOLOGY, 2, 217
- 2013, EXPERT REVIEW OF ENDOCRINOLOGY METABOLISM, 5, 449
- 2000, Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 5, 364
- 1992, Journal of Clinical Endocrinology & Metabolism, 3, 779
- 2000, Diabetic medicine : a journal of the British Diabetic Association, 2, 124
- 2005, Clinical endocrinology, 6, 683
- 2013, Fertility and sterility, 6, 1779
- 2012, Clinical endocrinology, 2, 207
- 2013, CLINICAL EPIDEMIOLOGY, 6, 1
- 2014, Human Reproduction, 10, 2333
- 2005, Clinical endocrinology, 3, 289
- 2013, Journal of Clinical Endocrinology & Metabolism, 12, 4565
Cited by
Joham, A. E., Norman, R. J., Stener-Victorin, E., Legro, R. S., Franks, S., Moran, L. J., Boyle, J., & Teede, H. J. (2022) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(22)00163-2 · Cited by 838
Stener-Victorin, E., Teede, H., Norman, R. J., Legro, R., Goodarzi, M. O., Dokras, A., Laven, J., Hoeger, K., & Piltonen, T. T. (2024) · Nature Reviews Disease Primers · doi:10.1038/s41572-024-00511-3 · Cited by 495
“PCOS emerges as a risk factor for multimorbidity and chronic medication use, even at postmenopause 34,63 .”
Kakoly, N. S., Khomami, M. B., Joham, A. E., Cooray, S. D., Misso, M. L., Norman, R. J., Harrison, C. L., Ranasinha, S., Teede, H. J., & Moran, L. J. (2018) · Human Reproduction Update · doi:10.1093/humupd/dmy007 · Cited by 384
Cesta, C. E., Månsson, M., Palm, C., Lichtenstein, P., Iliadou, A. N., & Landén, M. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.08.005 · Cited by 217
“The rate of prescriptions for antidepressants, neuroleptics, and anxiolytics was significantly higher in women with PCOS than in controls (Glintborg et al., 2015).”
BackgroundInsulin resistance and PCOS: chicken or egg?
Moghetti, P., & Tosi, F. (2021) · Journal of Endocrinological Investigation · doi:10.1007/s40618-020-01351-0 · Cited by 209
Metadata
- Authors
- Glintborg, D., Hass Rubin, K., Nybo, M., Abrahamsen, B., & Andersen, M.
- Affiliations
- University of Southern Denmark (DK)
- Corresponding author
- Glintborg, Dorte
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2015-05
- Volume
- 172
- Issue
- 5
- Pages
- 627-638
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2010569543
- Cited by
- 154
- References
- 56
- Citations by year
- 2026: 7 · 2025: 13 · 2024: 13 · 2023: 16 · 2022: 15 · 2021: 19 · 2020: 18 · 2019: 15 · 2018: 16 · 2017: 7 · 2016: 12 · 2015: 3
- FWCI
- 14.44
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, comorbidities, drug prescribing, type 2 diabetes, dyslipidemia, hypertension, stroke, thrombosis, cardiovascular disease, thyroid dysfunction, infertility, cardiometabolic risk, mental illness, Rotterdam criteria, young women
- MeSH terms
- Adolescent, Adult, Child, Denmark, Female, Humans, Insulin, Menstrual Cycle, Middle Aged, Polycystic Ovary Syndrome, Drug Prescriptions, Registries, Testosterone, Body Mass Index, Prevalence, Premenopause, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.